Clive L. Branch

Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A

Stephen G. Taylor, Martyn Wood, Nigel Austin et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 288 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Characterization of a CNS penetrant, selective M₁muscarinic receptor agonist, 77‐LH‐28‐1

Christopher J. Langmead, Nigel Austin, Clive L. Branch et al. · British Journal of Pharmacology · 2008 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Design and Synthesis of <i>trans</i>-<i>N</i>-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011):  A Potent and Selective Dopamine D₃ Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat

Geoffrey Stemp, Tracey Ashmeade, Clive L. Branch et al. · Journal of Medicinal Chemistry · 2000 · 129 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

Christopher J. Langmead, Victoria A. H. Fry, Ian T. Forbes et al. · Molecular Pharmacology · 2005 · 107 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Design and Synthesis of<i>trans</i>-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1<i>H</i>-3-benzazepine (SB-414796):  A Potent and Selective Dopamine D₃Receptor Antagonist

Gregor J. Macdonald, Clive L. Branch, Michael S. Hadley et al. · Journal of Medicinal Chemistry · 2003 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11